The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PCRT16-001: Phase II study of PEGPH20 plus pembrolizumab for patients (pts) with hyaluronan (HA)-high refractory metastatic pancreatic ductal adenocarcinoma (mPDA).
 
E. Gabriela Chiorean
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Seagen; Seagen; Seagen; Seagen; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics
Research Funding - AADi (Inst); AADi (Inst); AADi (Inst); AADi (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MacroGenics (Inst); MacroGenics (Inst); MacroGenics (Inst); MacroGenics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Seagen; Seagen; Seagen; Seagen
 
Paul S. Ritch
No Relationships to Disclose
 
David Bing Zhen
No Relationships to Disclose
 
Elizabeth Poplin
Research Funding - Neogenix Oncology (Inst); Neogenix Oncology (Inst); Neogenix Oncology (Inst); Neogenix Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology
 
Ben George
Honoraria - Newlink Genetics; Newlink Genetics; Newlink Genetics; Newlink Genetics
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Cook Medical; Cook Medical; Cook Medical; Cook Medical; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Ipsen; Ipsen; Ipsen; Ipsen; Merrimack; Merrimack; Merrimack; Merrimack; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; TERUMO; TERUMO; TERUMO; TERUMO
Research Funding - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); CeGaT (Inst); CeGaT (Inst); CeGaT (Inst); CeGaT (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Foundation Medicine (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Perthera; Perthera; Perthera; Perthera
Research Funding - Ipsen; Ipsen; Ipsen; Ipsen
Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme
 
Tomislav Dragovich
Employment - Taiho Pharmaceutical (I); Taiho Pharmaceutical (I); Taiho Pharmaceutical (I); Taiho Pharmaceutical (I)
Research Funding - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Medivir; Medivir; Medivir; Medivir; Rgenix; Rgenix; Rgenix; Rgenix
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme; Merrimack; Merrimack; Merrimack; Merrimack; Seagen; Seagen; Seagen; Seagen
Research Funding - AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme
 
Amy C. Stoll-D'Astice
No Relationships to Disclose
 
Stephanie Edwards
No Relationships to Disclose
 
Adam Rosenthal
No Relationships to Disclose
 
Shelley M. Thorsen
No Relationships to Disclose
 
Sunil R. Hingorani
Consulting or Advisory Role - Halozyme; Halozyme; Halozyme; Halozyme
Research Funding - Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst)